Dementia: Molecules, Methods and Measures

Partial table of contents: Molecules for Modeling Cognitive Impairment (J. Rusted & D. Warburton). A Comparison of the Animal Pharmacology of Nootropics and Metabolically Active Compounds (C. Nicholson). New Anti-Dementia Molecules (B. Costall & R. Naylor). Some Considerations on the Methodology of Clinical Trials with Potential Anti-Dementia Compounds in Patients with Alzheimer2s Disease (K. Siegfried). The Predictive Value of Volunteer Studies with Anti-Dementia Drugs (R. Spiegel). European Approaches to the Design of Drug Trials in Dementia (R. Engel, et al.). International Development of Anti-Dementia Drugs (B. Musch & J. Robin). The Development of the SKT Project (H. Erzigkeit). Appropriate Psychometric Testing of Cognitive Enhancers in Human Pharmacological Studies with Healthy Volunteers (H. Ott). EEG-Brain Mapping in Dementia and Gerontopsychopharmacology (B. Saletu). Critical Flicker Fusion in Gerontological Research: Clinical Implications for Alzheimer2s Disease (S. Curran). The Assessment of Quality of Life in Nootropic Drug Research: Some Questions (W. Deberdt & A. Brems). Intrusion Errors in Dementia: A New Look at an Old Measure (T. Lorscheid & S. Thompson). Index.G. K. Wilcock is the author of 'Dementia: Molecules, Methods and Measures' with ISBN 9780471928744 and ISBN 0471928747.